'Fingolimod' diaporamas de présentation

New and Emerging Therapies in MS: Is It Time to Change the Status Quo?

Anne H. Cross, MD Professor of Neurology Washington University School of Medicine St. Louis, Missouri. New and Emerging Therapies in MS: Is It Time to Change the Status Quo?. Outline. How have our goals been altered by the new MS therapies? Balancing efficacy with safety

1.22k views • 100 slides

Multiple Sclerosis (MS)

Multiple Sclerosis (MS). Dr Oliver Lily Consultant Neurologist Leeds General Infirmary. Multiple sclerosis. What is MS? What causes MS? Symptoms and signs of MS Making the diagnosis Investigations Treatments. Case Study: Ms A. 20 year old medical student

2.15k views • 60 slides

Drug Developments in 2010

767 views • 48 slides

Emerging Therapies for Multiple Sclerosis

Emerging Therapies for Multiple Sclerosis. Horea Rus MD PhD. approved. In phase II. Filed. In phase III. Existing Therapies and Emerging Therapies for MS. 2005. 2006. 2007. 2010. 2011. 2012. 2013. Orals. Injectables. BG 12 Oral Fumarate. Oral Cladribine. Rebif. Teriflunomide.

1.74k views • 31 slides

Multiple Sclerosis: Clinical Treatment and Current Research

Multiple Sclerosis: Clinical Treatment and Current Research. Walter Royal, III, MD Associate Professor of Neurology Maryland Center for Multiple Sclerosis Multiple Sclerosis Center of Excellence - East. Social Security Administration March 16, 2011. Presentation Outline.

484 views • 25 slides

Functional Anatomy of the Adaptive Immune Response

320 views • 22 slides

Emerging MS Therapies

Emerging MS Therapies. Limitations of Current Therapies. All are only partially effective All are injectable or IV and have side effects Risks vs benefits Existing therapies have advantage of long-term safety data Difficulty predicting therapeutic response

314 views • 14 slides

Figure 4 Proposed neurobiological roles of fingolimod in MS

Figure 4 Proposed neurobiological roles of fingolimod in MS. Aktas, O. et al. (2010) Fingolimod is a potential novel therapy for multiple sclerosis Nat. Rev. Neurol. doi:10.1038/nrneurol.2010.76.

302 views • 1 slides